Evidence that triglycerides are an independent coronary heart disease risk factor (Q34071541)

30 July 2017

1 reference

title

Evidence that triglycerides are an independent coronary heart disease risk factor (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

coronary artery disease

1 reference

Cullen P

1

1 reference

PubMed ID

11053704

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

American Journal of Cardiology

30 July 2017

1 reference

30 July 2017

86

1 reference

30 July 2017

943-949

1 reference

30 July 2017

9

1 reference

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Serum cholesterol and triglycerides in patients suffering from ischemic heart disease and in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Association of risk factor variables and coronary artery disease documented with angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Serum triglycerides, to be or not to be a risk factor for ischaemic heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Control of the trunk during walking in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Epidemiology of triglycerides: a view from Framingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

The triglyceride issue: a view from Framingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Plasma triglyceride level and mortality from coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Myocardial infarction in the familial forms of hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Atherogenesis: a postprandial phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Activation of coagulation factor VII during alimentary lipemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Postprandial dyslipidaemia in a nutshell: food for thought

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Purification of the human THP-1 monocyte-macrophage triglyceride-rich lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Hyperlipidaemia and renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Triglyceride concentration and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Comparison of statins in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901127-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(00)01127-9

1 reference

release_jrw342zbfzbz5c4zb242m5qkeu

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jrw342zbfzbz5c4zb242m5qkeu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

11053704

1 reference

PubMed ID

11053704